NCT03434197View on ClinicalTrials.gov

Safety and Efficacy of SFPP in Knee Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

January 11, 2021

Study Completion Date

January 11, 2021

Conditions
Osteoarthritis Knee Pain
Interventions
DRUG

Esflurbiprofen

A plaster containing 40 mg of Esflurbiprofen and 36.2 mg of Japanese Pharmacopoeia mentha oil per patch (10 × 14 cm)

DRUG

Diclofenac diethylamine

A gel containing 11.6 mg of Diclofenac diethylamine (equivalent to 10 mg of diclofenac sodium) per 1 g (1 tube contains 20 g)

Trial Locations (11)

Unknown

Klinik Perisai Husada, Bandung

Rumah Sakit Hasan Sadikin, Bandung

Rumah Sakit Umum Daerah Al Ihsan Bale Endah, Bandung

Rumah Sakit Anna Medika Bekasi, Jakarta

Rumah Sakit Cipto Mangunkusumo, Jakarta

Rumah Sakit Islam Pd. Kopi, Jakarta

Rumah Sakit Siloam Karawaci, Jakarta

Rheumatology and Allergy Clinic, Malang

Rumah Sakit UD Dr. Saiful Anwar, Malang

Rumah Sakit TNI AU Soemitro, Surabaya

Rumah Sakit UD Dr. Soetomo, Surabaya

All Listed Sponsors
lead

Taisho Pharmaceutical Co., Ltd.

INDUSTRY

NCT03434197 - Safety and Efficacy of SFPP in Knee Osteoarthritis | Biotech Hunter | Biotech Hunter